Specialist corporate finance house ReSolve has invested in an established R&D enterprise from its in-house capital fund to provide a short term funding facility.
Due diligence, full stakeholder engagement and regulatory compliance were all completed within six working days, the result of which means the innovative health-tech business will remain on track to achieve its 2018 strategic goals.
Cameron Gunn, founding partner of ReSolve, commented: ‘We continue to successfully seek out exciting mid-cap investment opportunities to create growth and value. Through ReSolve Capital, we were able to identify the company’s potential quickly and our accelerated but rigorous processes meant we could complete the transaction in a remarkably short timescale for a business with great vision and potential. As with all our investments, we hope to be working with the organisation in the long term, providing other innovative, independent solutions to their ongoing corporate finance needs.’
For any questions or further comments, please get in touch with Cameron Gunn via email@example.com.